沈逸青 博士后
研究方向
专注于脑出血脑损伤机制和神经影像学研究。在前期脑出血临床序贯研究基础上，旨在以降低脑出血死亡率和致残率为总体目标，利用深度学习、个体化功能图谱等技术，构建脑出血临床-分子-影像风险预警模型。结合脑出血后脑损伤的关键机制及靶标，建立脑出血一体化智慧诊疗体系，助力提高我国脑出血防治综合水平。
代表性文章
1. Luo S#, Yang WS#, Shen YQ#, Chen P, Zhang SQ, Jia Z, Li Q, Zhao JT, Xie P. The clinical value of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer-to-fibrinogen ratio for predicting pneumonia and poor outcomes in patients with acute intracerebral hemorrhage. Front Immunol. 2022; 13: 1037255.
2. Yang WS#, Shen YQ#, Yang X#, Li XH, Xu SH, Zhao LB, Li R, Xiong X, Bai SJ, Wu QY, Manaenko A, Li Q, Xie P. MicroRNA Transcriptomics Analysis Identifies Dysregulated Hedgehog Signaling Pathway in a Mouse Model of Acute Intracerebral Hemorrhage Exposed to Hyperglycemia. J Stroke Cerebrovasc Dis. 2022 Mar;31(3):106281.
3. Shen YQ#, Yang WS#, Xiong X, Li XH, Xiao ZS, Yu JL, Liu FY, Gui SW, Xie XF, Lv FJ, Zhao LB, Hu LB, Manaenko A, Xie P, Li Q. Integrated Multiomics Analysis Identifies a Novel Biomarker Associated with Prognosis in Intracerebral Hemorrhage. Oxidative Medicine and Cellular Longevity, 2021, 2021: 1-20.
4. Yang WS#, Shen YQ#, Zhang XD#, Zhao LB, Wei X, Xiong X, Xie XF, Li R, Deng L, Li XH, Lv XN, Lv FJ, Li Q, Xie P. Hydrocephalus Growth: Definition, Prevalence, Association with Poor Outcome in Acute Intracerebral Hemorrhage. Neurocrit Care. 2021 Aug;35(1):62-71.
5. Yang WS#, Shen YQ#, Wei X, Zhao LB, Liu QJ, Xie XF, Zhang ZW, Deng L, Lv XN, Zhang SQ, Li XH, Li Q, Xie P. New Prediction Models of Functional Outcome in Acute Intracerebral Hemorrhage: The dICH Score and uICH Score. Front Neurol. 2021 May 5；12:655800.
6. Yang WS#, Li R#, Shen YQ#, Wang XC, Liu QJ, Wang HY, Li Q, Yao GE, Xie P. Importance of lipid ratios for predicting intracranial atherosclerotic stenosis. Lipids Health Dis. 2020 Jul 4;19(1):160.
7. Li Q#, Shen YQ#, Xie XF#, Xue MZ, Cao D, Yang WS, Li R, Deng L, Lv FJ, Wu GF, Tang ZP, Xie P. Expansion-Prone Hematoma: Defining a Population at High Risk of Hematoma Growth and Poor Outcome. Neurocrit Care, 2019 Jun;30(3):601-608.
